TNFRSF10B and lung carcinoma: In H460 and primary human lung cancer cells, treatment with ONC201 (10 μM) similarly induced TRAIL (Fig 2G) and DR5 (Fig 2H) expression, as well as apoptosis activation (Fig 2I).